Background: KRAS oncogene is involved in colorectal carcinogenesis 22 to 45% of cases. mutations can render Epidermal Growth Factor Receptor (EGFR) inhibitors ineffective. The present study aimed determine the molecular diversity, frequency, and characteristics metastatic Colorectal Cancer (mCRC). gene contains 4 coding exons 1 non-coding exon, which exon 2 has highest mutation rate, directly a...